SEC Insider Transactions from Galletta Christopher.

Last updated: 2026-03-14 11:51 UTC | Total transactions: 9

Galletta Christopher has filed 9 insider transactions across 1 company since February 2024.

Most recent transaction: a grant/award of 35000 shares of Trevi Therapeutics, Inc. ($TRVI) on February 19, 2026.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Feb. 19, 2026 Trevi Therapeutics, Inc. $TRVI Galletta Christopher See Remarks A Stock Option (right to buy) 35000 $0.00 35,000.0000 145,104,986 9999.99% 0.02%
Dec. 2, 2025 Trevi Therapeutics, Inc. $TRVI Galletta Christopher See Remarks M Common Stock 4225 $0.51 26,095.0000 145,104,986 19.32% 0.00%
Dec. 2, 2025 Trevi Therapeutics, Inc. $TRVI Galletta Christopher See Remarks M Stock Option (right to buy) 4225 $0.00 15,775.0000 145,104,986 21.13% 0.00%
May 31, 2025 Trevi Therapeutics, Inc. $TRVI Galletta Christopher See Remarks A Performance Stock Option (right to buy) 8550 $0.00 13,110.0000 101,971,873 187.50% 0.01%
March 10, 2025 Trevi Therapeutics, Inc. $TRVI Galletta Christopher See Remarks A Performance Stock Option (right to buy) 4560 $0.00 4,560.0000 101,971,873 9999.99% 0.00%
Feb. 18, 2025 Trevi Therapeutics, Inc. $TRVI Galletta Christopher See Remarks A Stock Option (right to buy) 41000 $0.00 41,000.0000 101,971,873 9999.99% 0.04%
Dec. 13, 2024 Trevi Therapeutics, Inc. $TRVI Galletta Christopher See Remarks M Stock Option (right to buy) 15000 $0.00 20,000.0000 101,282,228 42.86% 0.01%
Dec. 13, 2024 Trevi Therapeutics, Inc. $TRVI Galletta Christopher See Remarks M Common Stock 15000 $0.51 19,935.0000 101,282,228 303.95% 0.01%
Feb. 15, 2024 Trevi Therapeutics, Inc. $TRVI Galletta Christopher See Remarks A Stock Option (right to buy) 28500 $0.00 28,500.0000 99,033,373 9999.99% 0.03%